Working along with insulin, this medication first came on the market in 2005 and goes by the trade name of Symlin. Diabetes patients have trouble controlling their blood sugar and converting glucose to energy for cellular use. These two drugs in combination help to regulate this process more efficiently. Symlin^® replaces the body’s amylin, a hormone that, along with insulin, helps to control the body’s blood sugar levels. Just as diabetics produce little or no insulin, amylin levels are also low or nonexistent. Amylin determines the sugar level in the blood, and how quickly it’s released. Insulin gets the sugar out of the blood and into muscles and tissues. This is the role that is taken over by Symlin. Diabetes patients use the drug to feel full after meals (a common symptom of diabetes is hunger, which leads to obesity). Less food means less sugar entering the blood stream. …